Type-1 diabetes
Type 1 diabetes is a chronic autoimmune disease in which immune-mediated destruction of pancreatic beta cells progressively reduces or eliminates endogenous insulin production. insulin deficiency prevents adequate uptake and utilization of glucose by insulin-responsive tissues, resulting in persistent hyperglycemia and abnormal metabolism of carbohydrates, fats, and proteins.
Type 1 diabetes is a chronic autoimmune disease in which immune-mediated destruction of pancreatic beta cells progressively reduces or eliminates endogenous insulin production. insulin deficiency prevents adequate uptake and utilization of glucose by insulin-responsive tissues, resulting in persistent hyperglycemia and abnormal metabolism of carbohydrates, fats, and proteins. Unlike type 2 diabetes, which is primarily associated with insulin resistance and relative insulin deficiency, type 1 diabetes generally requires lifelong exogenous insulin replacement. The disease can occur at any Age, although onset is common in children and adolescents as well as in adults.
Without sufficient insulin, excessive lipolysis and production of ketone bodies may lead to Diabetic ketoacidosis, a potentially life-threatening acute complication. Long-term hyperglycemia contributes to microvascular and macrovascular complications, making glycemic control a central therapeutic objective. hemoglobin A1c, continuous glucose monitor measurements, and time-in-range are commonly used to assess glucose exposure and daily glycemic variability. insulin delivery may involve multiple daily injections, insulin pumps, or Automated insulin Delivery systems; treatment must also account for hypoglycemia. The pathogenesis involves immune dysregulation, inflammation, and selective injury to beta cells, with genetic and environmental factors contributing to disease susceptibility. Type 1 diabetes is associated with other autoimmune diseases, including celiac disease.
Where the papers sit
10 papers from the last 6 months study type-1 diabetes directly · updated from PubMed 1 Oct 2026
Study type 0 clinical trials · 4 observational · 5 human data · 1 unclassified
Themes 3 themes
-
Diabetes Risk and Management
Diabetes care is moving toward combining metabolic, psychosocial, digital and genetic measures rather than relying on glycemic control alone. BMI normalization, hypoglycemia, depression and diabetes distress recur as clinically important outcomes across type 1 and type 2 diabetes. Wearable-data summaries, Android Artificial Pancreas System use and genetic risk scoring extend individualized monitoring and treatment selection. The evidence remains broad, with clinical utility and meaningful outcome thresholds still being defined.
6 papers · 60%
-
Childhood Autoimmune Epidemiology
Population-based cohorts are clarifying how childhood autoimmune disease incidence and later type 1 diabetes complications vary across patients. Age at diagnosis and diabetes duration recur as major determinants of adult complications. Incidence estimates and regression-based risk analyses remain central, with geographic variation also under study. The work is building a clearer long-term epidemiology rather than testing a specific intervention.
2 papers · 20%
-
Dietary Determinants of Autoimmunity
Dietary antioxidant exposure is being examined as a possible environmental influence on islet autoimmunity and progression to type 1 diabetes. Vitamin C, retinol, carotenoids and tocopherols are recurring exposures, assessed through intake and biomarker status in children. Associations are considered alongside genetic susceptibility and other environmental determinants. Prospective studies are narrowing risk signals, but causality and effective dietary prevention remain unresolved.
2 papers · 20%
Papers
The 10 papers from the last 6 months that study type-1 diabetes directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Diabetes Risk and Management (6)
- Clinically relevant depression in patients with type 1 and type 2 diabetes; a nationwide study (TEMD-2 depression). Endocrine · 9 Sept 2026 PMID 42714690
- Clinical Utility of a Type 1 Diabetes Genetic Risk Score Measured as Part of MODY Genetic Testing. Diabetes care · 18 Aug 2026 PMID 42612686
- BMI Normalization Is Associated With Lower Risk of Progression to Type 1 Diabetes, Primarily in Youth. Diabetes care · 16 Jul 2026 PMID 42461847
- Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions. Statistics in medicine · 30 Jun 2026 PMID 42380066
- Clinical characteristics, glycemic control & quality of life of patients using Android Artificial Pancreas System (AAPS) in Brazil. Archives of endocrinology and metabolism · 25 Jun 2026 PMID 42348779
- What Is a Clinically Meaningful Change in Diabetes Distress? Findings for Diabetes Care and Research From the SFDT1 Cohort. Diabetes, obesity & metabolism · 12 Jun 2026 PMID 42283146
Childhood Autoimmune Epidemiology (2)
- Adult Complications of Childhood-Onset Type 1 Diabetes Vary With Age at Diagnosis: A Population-Based Study. Diabetes care · 13 Aug 2026 PMID 42594337
- Incidence and co-occurrence of six autoimmune diseases in childhood: a population-based cohort study in Norway. The Lancet. Child & adolescent health · 19 Apr 2026 PMID 42001894
Dietary Determinants of Autoimmunity (2)
- Dietary vitamin C intake and the risk of islet autoimmunity and type 1 diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY) Study. European journal of nutrition · 24 Sept 2026 PMID 42782404
- Retinol, Carotenoid, and Tocopherol Intake and Status, and the Risk of Islet Autoimmunity and Type 1 Diabetes: The Environmental Determinants of Diabetes in the Young Study. Diabetes/metabolism research and reviews · 26 Jun 2026 PMID 42361128
By study type
Observational studies and case reports (4)
- Dietary vitamin C intake and the risk of islet autoimmunity and type 1 diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY) Study. European journal of nutrition · 24 Sept 2026 PMID 42782404
- Clinically relevant depression in patients with type 1 and type 2 diabetes; a nationwide study (TEMD-2 depression). Endocrine · 9 Sept 2026 PMID 42714690
- Retinol, Carotenoid, and Tocopherol Intake and Status, and the Risk of Islet Autoimmunity and Type 1 Diabetes: The Environmental Determinants of Diabetes in the Young Study. Diabetes/metabolism research and reviews · 26 Jun 2026 PMID 42361128
- Incidence and co-occurrence of six autoimmune diseases in childhood: a population-based cohort study in Norway. The Lancet. Child & adolescent health · 19 Apr 2026 PMID 42001894
Human data, design not indexed (5)
- Clinical Utility of a Type 1 Diabetes Genetic Risk Score Measured as Part of MODY Genetic Testing. Diabetes care · 18 Aug 2026 PMID 42612686
- Adult Complications of Childhood-Onset Type 1 Diabetes Vary With Age at Diagnosis: A Population-Based Study. Diabetes care · 13 Aug 2026 PMID 42594337
- BMI Normalization Is Associated With Lower Risk of Progression to Type 1 Diabetes, Primarily in Youth. Diabetes care · 16 Jul 2026 PMID 42461847
- Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions. Statistics in medicine · 30 Jun 2026 PMID 42380066
- Clinical characteristics, glycemic control & quality of life of patients using Android Artificial Pancreas System (AAPS) in Brazil. Archives of endocrinology and metabolism · 25 Jun 2026 PMID 42348779
Unclassified: not yet indexed with MeSH (1)
- What Is a Clinically Meaningful Change in Diabetes Distress? Findings for Diabetes Care and Research From the SFDT1 Cohort. Diabetes, obesity & metabolism · 12 Jun 2026 PMID 42283146
Written from 10 PubMed abstracts, each one listed by PMID above. Published: 2026-08-20. Drafted by language models from published abstracts; not medical advice.